STAT Pharmalittle Were reading about Pfizers new RD head, Merck and JJ job cuts in China, and more
| MNBIX Fund | USD 20.50 0.18 0.89% |
Slightly above 51% of Pro Blend's investor base is interested to short. The analysis of overall sentiment of trading Pro Blend Extended Term mutual fund suggests that many investors are impartial at this time. Pro Blend's investing sentiment can be driven by a variety of factors including economic data, Pro Blend's earnings reports, geopolitical events, and overall market trends.
Pro |
Pfizer tapped its chief oncology officer, Chris Boshoff, to head all of its research and development efforts
Read at statnews.com
 |
Pro Blend Fundamental Analysis
We analyze Pro Blend's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pro Blend using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pro Blend based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Pro Blend is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Pro Blend Extended Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pro Blend mutual fund to make a market-neutral strategy. Peer analysis of Pro Blend could also be used in its relative valuation, which is a method of valuing Pro Blend by comparing valuation metrics with similar companies.
Peers
Pro Blend Related Equities
| THQ | Tekla Healthcare | 2.37 | ||||
| AHSCX | Alger Health | 0.67 | ||||
| LOGSX | Live Oak | 0.46 | ||||
| HIAHX | Hartford Healthcare | 0.29 | ||||
| GGHYX | Invesco Global | 0.05 |
Other Information on Investing in Pro Mutual Fund
Pro Blend financial ratios help investors to determine whether Pro Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pro with respect to the benefits of owning Pro Blend security.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |